Logo for Revolution Medicines Inc

Revolution Medicines Investor Relations Material

Latest events

Logo for Revolution Medicines Inc

Q1 2024

Revolution Medicines
Logo for Revolution Medicines

Q1 2024

8 May, 2024
Logo for Revolution Medicines

Q4 2023

26 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Revolution Medicines Inc

Access all reports
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The Company's portfolio includes programs that target shared signaling mutations involving RAS and EGFR pathways. Through its technology platform of small molecules that enter cells through multiple mechanisms of action, Revolution Medicines aims to significantly increase drug concentrations at key adverse driver points required for cell growth and survival.